Status:
COMPLETED
Bio Impedance Electrical Analysis to Predict Outcome After Cardiac Surgery
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Post Operative Care After Cardiac Surgery With Cardio Pulmonary Bypass
Eligibility:
All Genders
18+ years
Brief Summary
Phase angle determined by bioelectrical impedance analysis is a strong prognostic factor in several medical areas as clinical nutrition, nephrology, infectious disease, oncology. Inflammation, frailty...
Eligibility Criteria
Inclusion
- Age higher than 18
- Cardiac surgery with cardiopulmonary bypass
- Bioelectrical impedance analysis the day of the admission in intensive care unit
Exclusion
- Left ventricular assist device
- Limitations des thérapeutiques actives en place pour le patient
- Patient opposition to the use of his health data
- Invalid bioelectrical impedance analysis
- Advanced directives to withhold or withdraw life-sustaining treatment
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT05229159
Start Date
July 1 2021
End Date
November 30 2021
Last Update
February 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital cardiologique Louis Pradel Groupe Hospitalier Est
Bron, Rhône, France, 69500